Latest News - Thermo Fisher Scientific
Top Corporates Hub
Thermo Fisher Scientific
U.S. Exosomes Market to Skyrocket During 2026-2033, Reaching $716.8 Million - Analysis of Lucrative Business Opportunities and Key Players; Danaher, Thermo Fisher Scientific, Hologic, Fujifilm, Lonza and More
20.03.2026 10:45
U.S. Exosomes Market U.S. Exosomes Market Dublin, March 20, 2026 (GLOBE NEWSWIRE) -- The "U.S. Exosomes Market Size, Share & Trends Analysis Report by Product & Service, Application, Workflow, End Use, and Segment Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.The U.S. exosomes market size, valued at USD 115.6 million in 2025, is projected to surge to USD 716.8 million by 2033, marking a robust CAGR of 25.75% from 2026 to 2033. The market's expansion is largely driven
Thermo Fisher: A High-Quality Life Science Platform Positioned For Growth
18.03.2026 05:04
Thermo Fisher shares have declined approximately 20% YTD, presenting an attractive long-term entry point. See why I rate TMO stock a Buy now.
Drug Development Insights: What New Industry Data Reveals for 2026, Upcoming Webinar Hosted by Xtalks
11.03.2026 12:30
The future for drug developers is increasingly shaped by how effectively they adapt to complexity, change and rising pressure across the development landscape.
Thermo Fisher Scientific Inc. (TMO) Announces the Opening of Cryo-Electron Microscopy Drug Discovery Center in South San Francisco
10.03.2026 09:38
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best stocks that will always grow. Thermo Fisher Scientific Inc. (NYSE:TMO) announced on March 5 the opening of its Cryo-Electron Microscopy (cryo-EM) Drug Discovery Center in South San Francisco, offering biotechnology and pharmaceutical innovators with immersive, hands-on access to advanced cryo-EM technologies specialized to expedite structural […]
[Latest] Global Viral Vaccine Cell Culture Media Market Size/Share Worth USD 3.5 Billion by 2035 at a 6.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
10.03.2026 06:30
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Viral Vaccine Cell Culture Media Market size & share revenue was valued at approximately USD 1.9 Billion in 2025 and is expected to reach USD 2.1 Billion in 2026 and is expected to reach around USD 3.5 Billion by 2035, at a CAGR of 6.2% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Thermo Fisher Scien
Thermo Fisher Scientific Inc. (TMO) Launches New Color-Based Culture Media for Faster Detection of Candida Infections
08.03.2026 11:59
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best stocks with huge upside potential to buy according to Reddit. Thermo Fisher Scientific Inc. (NYSE:TMO) announced on March 2 the launch of Thermo Scientific™ Brilliance™ Candida 2 Agar and Spectra™ Candida Agar, which are new color-based culture media to help laboratories in the quick detection […]
Is This the Right Time to Hold Thermo Fisher Stock in Your Portfolio?
06.03.2026 13:22
TMO's acquisitions and resilient pharma, biotech and diagnostics demand support growth, but currency swings and fierce competition remain risks.
Thermo Fisher Expands Drug Discovery And Diagnostics While Shares Lag Targets
06.03.2026 13:07
Thermo Fisher Scientific (NYSE:TMO) opened its Cryo Electron Microscopy Drug Discovery Center in South San Francisco. The company introduced new culture media to support rapid Candida detection. Thermo Fisher also launched a pharmacogenetic test to support personalized dosing of immunosuppressive therapy for transplant patients. For investors tracking NYSE:TMO, these product launches sit within the company’s core strengths in life science tools, diagnostics, and pharma services. Cryo...
[Latest] Global Malaria Diagnostics Market Size/Share Worth USD 1.45 Billion by 2035 at a 5.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
04.03.2026 19:30
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Malaria Diagnostics Market size & share revenue was valued at approximately USD 0.90 Billion in 2025 and is expected to reach USD 0.95 Billion in 2026 and is expected to reach around USD 1.45 Billion by 2035, at a CAGR of 5.2% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Abbott Laboratories, Access B
PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub
03.03.2026 15:15
PACB teams with DNAstack to launch a global HiFi genome network, linking 10,000+ sequences to boost rare disease research without moving data.
Thermo Fisher Scientific Inc. (TMO) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
03.03.2026 12:32
Thermo Fisher Scientific Inc. (TMO) 47th Annual Raymond James Institutional Investor Conference March 3, 2026 9:15 AM ESTCompany ParticipantsMarc Casper -...
Chemical Concentration Monitor Industry Research and Global Market Forecast Report 2025-2030
03.03.2026 09:04
The global chemical concentration monitor market, valued at USD 6.90 billion in 2025, is forecast to reach USD 9.36 billion by 2030, with a CAGR of 6.3%. Boosted by real-time, precise measurement needs in industrial processes, market growth is driven by process automation, environmental regulations, and quality control demands. Technological advances in optical and ultrasonic sensing, IoT, and AI enhance system efficiency. Rapid expansion in chemicals, pharmaceuticals, and semiconductors fuels d
Thermo Fisher Launches TacroType Test As Shares Trade Below Targets
02.03.2026 07:09
Thermo Fisher Scientific (NYSE:TMO) launched its TacroType Pharmacogenetic Test for transplant patients. The test is designed to support more personalized tacrolimus dosing based on a patient's genetic profile. The product targets transplant centers and clinicians involved in post transplant medication management. Thermo Fisher Scientific, traded as NYSE:TMO, is a large player in life sciences tools and diagnostics, supplying instruments, tests and services across research and clinical...
Here’s What Analysts Think About Thermo Fisher Scientific (TMO) Post Earnings
27.02.2026 04:53
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best strong buy healthcare stocks to invest in. Thermo Fisher Scientific Inc. (NYSE:TMO) reported its fiscal Q4 and full-year 2025 results on January 29, announcing that fiscal Q4 revenue grew 7% to $12.21 billion. GAAP diluted earnings per share for the quarter grew 9% to $5.21, […]
Thermo Fisher Scientific Introduces New Laboratory Developed Test to Help Transplant Patients Receive the Right Dose of Critical Anti-Rejection Medication Sooner
26.02.2026 13:30
WEST HILLS, Calif., February 26, 2026--Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the TacroType™ Pharmacogenetic Test, a new laboratory developed test designed to help inform clinicians on dosing tacrolimus, a commonly prescribed immunosuppressive drug for transplant recipients to lower the risk of rejection.
[Latest] Global Laboratory Informatics Market Size/Share Worth USD 8.21 Billion by 2035 at a 5.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
26.02.2026 12:30
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Laboratory Informatics Market size & share revenue was valued at approximately USD 4.89 Billion in 2025 and is expected to reach USD 5.15 Billion in 2026 and is expected to reach around USD 8.21 Billion by 2035, at a CAGR of 5.32% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Abbott Laboratories, Agil
Why Analysts Are Closely Watching Thermo Fisher Scientific Inc. (TMO)
26.02.2026 02:08
Thermo Fisher Scientific Inc. (NYSE:TMO) is among the best stocks in each sector in 2026. On February 9, Matt Larew, an analyst at William Blair, reiterated a Buy rating on Thermo Fisher Scientific Inc. (NYSE:TMO). Blair is among the 90% of analysts bullish on the stock, with the remaining 10% neutral. The 1-year median price target […]
Thermo Fisher Scientific Inc. (TMO) Carries a Mid-Single Digit Organic Growth Forecast
24.02.2026 19:30
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the 10 best life sciences stocks to buy according to hedge funds. On January 30, Daniel Arias of Stifel Nicolaus maintained a Buy rating on Thermo Fisher Scientific Inc. (NYSE:TMO), with a $700 price target. The analyst reflected on the company’s strong finish to 2025, highlighting that […]
Henry Schein Q4 Earnings Call Highlights
24.02.2026 16:47
Henry Schein (NASDAQ:HSIC) reported fourth-quarter 2025 results on Feb. 24, 2026, highlighting what management described as its “highest sales growth in 15 quarters,” alongside progress on its 2025–2027 BOLD+1 strategic plan and an update to its leadership transition. Leadership transition and stra